An Exploration of Fisetin’s Potential as a Senolytic in Autoimmune Thyroiditis

Fisetin clinical trials in patients with thyroiditis autoimmune

Senolitics are one of the best treatments for a number of causes of aging. Fisetin is one of the agents which has shown a senolytic action.

We chose to test fisetin on a patient with autoimmune thyroiditis because of its availability and safety. We chose to focus on the immune system, rather than chronic inflammation, as opposed to most other trials.

We need your help to pay for this test.

Clinical trials for drugs that target extracellular and intracellular damages leading to aging of the body began in recent years. More information can be found here [1].

Senescent cells, for example, accumulate with age in our bodies. Their abnormal metabolism causes chronic inflammation and they cannot perform their normal functions.

Recent studies have focused on senolitics – substances that induce the apoptosis of senescent cell. They found that after destroying senescent cell in mice, the function and appearance of the body improved.


Clinical trials of Fisetin in a person with autoimmune thyroiditis

Leave a Reply

Your email address will not be published. Required fields are marked *